Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -171.63 | -15.27 |
PEG Ratio (TTM) | -8.58 | -4.35 |
P/S Ratio (TTM) | 1.95 | 45.97 |
P/B Ratio (TTM) | 150.71 | 28.96 |
P/FCF Ratio (TTM) | -37.05 | -2.59 |
Price to 5YR AVG Earnings Ratio | -36.70 | -5.56 |
Price to 5YR AVG FCF Ratio | -86.17 | -12.33 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -2.37% | -19.06% |
ROE (TTM) | 66.22% | 15.70% |
Net Profit Margin (TTM) | -1.12% | -813.88% |
ROIC 5YR AVG | -42.96% | 3.12% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 333.03% | -479.28% | -503.21% |
Revenue | 4.18% | 22.03% | 13.78% |
Net Income | 333.39% | -491.09% | -516.64% |
Cash Flow | -106.88% | 128.22% | 18.07% |
Health (9%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.75 | 5.56 |
Quick Ratio (TTM) | 0.75 | 5.34 |
D/E Ratio (TTM) | 7.89 | 0.95 |
Interest Coverage (TTM) | N/A | -6.44 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 12.45 |
LTL to 5YR AVG FCF | -5.03 | 0.11 |
Shares Outstanding Growth 5YR AVG | 3.70% | 37.46% |